Search research articles
Contact Us
Filters
Showing results (391-400 of 404) with videos related to
Page
of 41
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies
George T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Blood Cancer Journal
|
November 5, 2016
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
A Paulus, S Akhtar, T R Caulfield, et al.
Annals of Neurology
|
June 16, 2025
Blood α-Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies
George T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Transplantation and Cellular Therapy
|
December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy
Othman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Annals of Neurology
|
December 15, 2018
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
David Coughlin, Sharon X Xie, Mendy Liang, et al.
Journal of Amino Acids
|
November 8, 2014
Amino Acid compositions of 27 food fishes and their importance in clinical nutrition
Bimal Mohanty, Arabinda Mahanty, Satabdi Ganguly, et al.
Scientific Reports
|
June 10, 2022
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients
Fadhel A Alomar, Marai N Alshakhs, Salah Abohelaika, et al.
Cancer
|
February 14, 2022
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study
Pallawi Torka, Othman S Akhtar, Nishitha M Reddy, et al.
Contemporary Clinical Trials
|
June 17, 2018
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management
N Metrebian, T Weaver, S Pilling, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 404) with videos related to
Sort By:
Page
of 41
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies
George T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Blood Cancer Journal
|
November 5, 2016
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
A Paulus, S Akhtar, T R Caulfield, et al.
Annals of Neurology
|
June 16, 2025
Blood α-Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies
George T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Transplantation and Cellular Therapy
|
December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy
Othman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Annals of Neurology
|
December 15, 2018
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
David Coughlin, Sharon X Xie, Mendy Liang, et al.
Journal of Amino Acids
|
November 8, 2014
Amino Acid compositions of 27 food fishes and their importance in clinical nutrition
Bimal Mohanty, Arabinda Mahanty, Satabdi Ganguly, et al.
Scientific Reports
|
June 10, 2022
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients
Fadhel A Alomar, Marai N Alshakhs, Salah Abohelaika, et al.
Cancer
|
February 14, 2022
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study
Pallawi Torka, Othman S Akhtar, Nishitha M Reddy, et al.
Contemporary Clinical Trials
|
June 17, 2018
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management
N Metrebian, T Weaver, S Pilling, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
Page
of 41